ERBB2 and ductal breast carcinoma in situ: However, a higher incidence rate of adjacent DCIS is seen in studies assessing its presence in surgical specimens of patients undergoing upfront surgery, i.e., 57–72% in HER2-positive IBC [13, 15, 17].